Two Biotechs Poised For Big Moves On Monday (Sana Biotechnology | Lineage Cell Therapeutics) Catalyst: Invited six-month ...

Sana Biotechnology, Inc. (NASDAQ:SANA) ranks among the best CRISPR stocks to buy. On June 24, Citizens JMP reaffirmed its $5 ...

Eolo Pharma, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, today announced the publication of its first-in-human study in Nature Metabolism, ...

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 10 best healthcare penny stocks to buy according to analysts.

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. On May 14, ...

Sana is Incorporating the Tested Immune Evasion Technology to Develop SC451, a HIP-modified, Stem Cell-Derived Therapy as a One-Time Treatment for Patients with Type 1 Diabetes, with a Goal of Normal ...

Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetesSEATTLE, June 09, 2025 (GLOBE NEWSWIRE) -- ...

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells ...

Short interest in Sana Biotechnology Corp (XNAS:SANA) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.

This press release contains forward-looking statements about Sana Biotechnology, Inc. (the "Company,” "we,” "us,” or "our”) within the meaning of the federal securities laws, including those related ...

View the latest Sana Biotechnology Inc. (SANA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Check out our SANA stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.